Femme et Homme
- | Pays :
- Sweden
- | Organes : -
- | Spécialités : -
Extrait
This study is designed to evaluate the safety, tolerability and PK of AZD1446 in Subjects when given as multiple dose administration for either 7 Days (Day 1 single dose, Day 2-6 multiple doses) in Part A and optionally at fractionated doses for 1 Day in Part B.
Critère d'inclusion
- Healthy